期刊文献+

血小板提取液NPY与NT在血液透析中的表达及意义 被引量:2

Expression of the platelet extract's neuropeptide and neurotensin in hemodialysis
下载PDF
导出
摘要 目的:探讨血液透析(HD)过程血小板中神经肽Y(NPY)与神经降压素(NT)的含量变化及意义。方法:HD患者35例,对照组30例。采用放射免疫分析法测定血小板提取液和血浆中NPY及NT的含量。结果:与对照组比较,HD患者血小板提取液NPY含量明显降低,血浆中NPY含量明显增高,血小板提取液与血浆NT含量均显著升高。与HD前比较,HD后血浆NT与血小板NPY均明显增高,血小板中NT与血浆NPY明显降低,两者具有显著相关性。结论:在HD过程中,血小板释放的NPY可能是造成肾性高血压和肾血管痉挛的重要病理因素。 Objective: To study the changes of neuropeptide Y(NPY) and neurotensin (NT) in platelet extract and plasma in hemodialysis (HD). Methods: There were 35 HD patients and 30 controls.NPY and NT in platelet extract and in plasma were measured by radioimmunity analysis. Results: When compared with control group, NPY was significantly higher in platelet extact and lower in the plasma, while NT was higher both in platelet extract and in plasma in HD patients. When compared with those before HD,NT in plasma and NPY in platelet extract signficantly increased,while NT in platelet extract and NPY in plasma significantly decreased after HD. NPY related to NT significantly. Conclusion: NPY,secreted by platelets, may play an important role in the pathogenesis of renal hypertension and renal vasospasm in HD.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 1999年第6期283-284,共2页 Chinese Journal of Immunology
关键词 神经肽Y 神经降压素 血小板 血浆 血液透析 Neuropeptide YNeurotensinPlateletPlasmaHemodialysis
  • 相关文献

参考文献2

二级参考文献3

  • 1韩启德,Neurosci Lett,1989年,104卷,141页
  • 2韩启德,生理科学,1989年,9卷,6页
  • 3韩启德,J Cardiovasc Pharmacol,1987年,9卷,675页

共引文献18

同被引文献25

  • 1倪蓝,卢银红.磺柳酸法、尿液干化学分析仪法与双缩脲比色法检测尿蛋白定量的对比分析[J].中国误诊学杂志,2009,9(1):40-41. 被引量:3
  • 2郑健.小儿原发性肾病综合征中医辨证施治的临床思维[J].中华中医药杂志,2007,22(4):225-227. 被引量:11
  • 3蔡强.神经降压素[J].国外医学消化系统疾病分册,1986,3:129-129.
  • 4Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y a novel brain peptide with structural similarities to peptide Y and pancreatic polypeptide [ J]. Nature, 1982,296(5858 ) :659-660.
  • 5Michel MC,Beck-Sickinger A, Cox H, et al. XVI International union of pharmacology recommendations for the nomenclature of neuropeptide Y,peptide YY,and pancreatic polypeptide receptors [ J ]. Pharmacol Rev, 1998,50 ( 1 ) : 143-150.
  • 6Bitehof A, Michel MC. Renal effects of neuropeptide Y [ J ]. Eur J Physiol, 1998,435 (4) :443-453.
  • 7Ito H,Morita T,Suehiro T,et al. Neuropeptide Y YI receptor polymorphism as a prognostic predictor in Japanese patients with lgA nephropathy [ J ]. Clin Nephrol, 1999,51 ( 5 ) :272-279.
  • 8Mahns DA,Kelly C, McCloskey DI,et al. NPY Y2 reeeptor agonist, N-acetyl [ Leu28, Leu31 ] NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs[ J ]. J Auton Nerv Syst, 1999, 78(1 ) :10-17.
  • 9Bischoff A, Michel MC. Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion [ J ]. Can J Physiol Pharmacol,2000,78 ( 2 ) :93-99.
  • 10Dubinion JH,Mi Z, Jackson EK. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats[ J ]. J Pharmacol Exp Ther,2006,317 (3): 1330-1336.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部